PGIM Jennison Health Sciences A (PHLAX)
| Fund Assets | 1.36B |
| Expense Ratio | 1.13% |
| Min. Investment | $1,000 |
| Turnover | 79.00% |
| Dividend (ttm) | 5.31 |
| Dividend Yield | 13.43% |
| Dividend Growth | 177.71% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 20, 2024 |
| Previous Close | 37.60 |
| YTD Return | 10.07% |
| 1-Year Return | 14.84% |
| 5-Year Return | 52.98% |
| 52-Week Low | 29.55 |
| 52-Week High | 42.43 |
| Beta (5Y) | n/a |
| Holdings | 52 |
| Inception Date | Jun 30, 1999 |
About PHLAX
PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.
Performance
PHLAX had a total return of 14.84% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.11%.
Top 10 Holdings
48.12% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.40% |
| Prudential Govt Money Mkt Fd | n/a | 5.86% |
| Thermo Fisher Scientific Inc. | TMO | 5.07% |
| argenx SE | ARGX | 4.28% |
| UCB SA | UCB | 3.59% |
| Danaher Corporation | DHR | 3.48% |
| UnitedHealth Group Incorporated | UNH | 3.22% |
| Arcutis Biotherapeutics, Inc. | ARQT | 3.15% |
| Neurocrine Biosciences, Inc. | NBIX | 3.06% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.01% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 20, 2024 | $5.31325 | Dec 20, 2024 |
| Dec 20, 2023 | $1.91322 | Dec 20, 2023 |
| Dec 20, 2022 | $0.61624 | Dec 20, 2022 |
| Dec 20, 2021 | $14.02528 | Dec 20, 2021 |
| Dec 20, 2019 | $1.43164 | Dec 20, 2019 |
| Dec 20, 2018 | $4.77761 | Dec 20, 2018 |